Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2009 2
2010 2
2012 1
2013 1
2014 9
2015 5
2016 4
2017 1
2018 2
2019 1
2020 4
2021 4
2022 3
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

36 results

Results by year

Filters applied: . Clear all
Page 1
Switching to bictegravir/emtricitabine/tenofovir alafenamide (BIC/FTC/TAF) plus darunavir/cobicistat in heavily antiretroviral-experienced, virologically suppressed HIV-infected adults receiving complex regimens.
Podzamczer D, Imaz A, Lopez-Lirola A, Knobel H, Masiá M, Fanciulli C, Hernández C, Lagarde M, Gutierrez A, Curran A, Morano L, Montero-Alonso M, Troya J, Rigo R, Casadellà M, Navarro-Alcaraz A, Ardila F, Parera M, Bernal E, Echeverria P, Estrada V, Hidalgo-Tenorio C, Macias J, Prieto P, Portilla J, Valencia E, Vivancos MJ, Rivero A. Podzamczer D, et al. Among authors: echeverria p. J Antimicrob Chemother. 2023 Nov 6;78(11):2696-2701. doi: 10.1093/jac/dkad285. J Antimicrob Chemother. 2023. PMID: 37725999 Clinical Trial.
High Prevalence of Sarcopenia in HIV-Infected Individuals.
Echeverría P, Bonjoch A, Puig J, Estany C, Ornelas A, Clotet B, Negredo E. Echeverría P, et al. Biomed Res Int. 2018 Jul 12;2018:5074923. doi: 10.1155/2018/5074923. eCollection 2018. Biomed Res Int. 2018. PMID: 30112397 Free PMC article.
Nonnucleoside Reverse-transcriptase Inhibitor- vs Ritonavir-boosted Protease Inhibitor-based Regimens for Initial Treatment of HIV Infection: A Systematic Review and Metaanalysis of Randomized Trials.
Borges ÁH, Lundh A, Tendal B, Bartlett JA, Clumeck N, Costagliola D, Daar ES, Echeverría P, Gisslén M, Huedo-Medina TB, Hughes MD, Huppler Hullsiek K, Khabo P, Komati S, Kumar P, Lockman S, MacArthur RD, Maggiolo F, Matteelli A, Miro JM, Oka S, Petoumenos K, Puls RL, Riddler SA, Sax PE, Sierra-Madero J, Torti C, Lundgren JD. Borges ÁH, et al. Among authors: echeverria p. Clin Infect Dis. 2016 Jul 15;63(2):268-80. doi: 10.1093/cid/ciw236. Epub 2016 Apr 18. Clin Infect Dis. 2016. PMID: 27090986 Free PMC article. Review.
Accentuated aging associated with HIV in a Mediterranean setting occurs mainly in persons aged>70 years: a comparative cohort study (Over50 cohort).
Negredo E, Loste C, Puig J, Echeverría P, Fumaz CR, Muñoz-Moreno JA, Lemos B, Martínez A, Tamayo F, Saiz M, Estany C, Matarrodona M, Bonjoch A, Blanco N, Satorra P, Clotet B. Negredo E, et al. Among authors: echeverria p. AIDS Care. 2022 Feb;34(2):155-162. doi: 10.1080/09540121.2021.1998314. Epub 2021 Nov 7. AIDS Care. 2022. PMID: 34743624
A randomized pilot trial to evaluate the benefit of the concomitant use of atorvastatin and Raltegravir on immunological markers in protease-inhibitor-treated subjects living with HIV.
Negredo E, Jiménez M, Puig J, Loste C, Pérez-Álvarez N, Urrea V, Echeverría P, Bonjoch A, Clotet B, Blanco J. Negredo E, et al. Among authors: echeverria p. PLoS One. 2020 Sep 17;15(9):e0238575. doi: 10.1371/journal.pone.0238575. eCollection 2020. PLoS One. 2020. PMID: 32941476 Free PMC article. Clinical Trial.
36 results